Methimazole

甲巯咪唑

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMethimazole
Drug Alias Namethiamazolum甲硫噻唑甲硫咪唑Thiamazole他巴唑 +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThyroid peroxidase inhibitors
TargetsThyroid peroxidase
Therapy Area/IndicationsHyperthyroidismHyperparathyroidismGraves Disease +[6] 
Global Approved IndicationsHyperthyroidismHyperparathyroidism
Approved Indications in ChinaHyperparathyroidism
Original Approved Country/TerritoryUnited States
Original Approved Date1950/06/21
Country/TerritoryUnited StatesItalyBrazil +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of PisaTianjin Tianyao Pharmaceutical Co Ltd
Inactive CompaniesNational Institute Of Arthritis And Musculoskeletal And Skin DiseasesFederal University Of Rio Grande Do SulKing Pharmaceuticals Inc
Active IndicationsHyperparathyroidismGraves Ophthalmopathy
Inactive IndicationsHyperthyroidismGraves DiseaseDermatomyositis +[4] 

Other Information

ATC CodeH03BB02
Related LinksWikipediaDrugBankKEGG